XML 35 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information
3 Months Ended
Apr. 02, 2021
Segment Reporting [Abstract]  
Segment Information

15. Segment Information

Reportable Segments

The Company’s Chief Operating Decision Maker (“CODM”) utilizes financial information to make decisions about allocating resources and assessing performance for the entire Company. The Company evaluates the performance of, and allocates resources to, its segments based on revenue, gross profit and operating profit. The Company’s reportable segments have been identified based on commonality and adjacency of technologies, applications and customers amongst the Company’s individual product lines. The Company determined that disclosing revenue by specific product was impracticable due to the highly customized and extensive portfolio of technologies offered to customers.

Based upon the information provided to the CODM, the Company has determined that it operates in three reportable segments: Photonics, Vision, and Precision Motion. The reportable segments and their principal activities consist of the following:

Photonics

The Photonics segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products to customers worldwide. The segment serves highly demanding photonics-based applications for advanced industrial processes, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The vast majority of the segment’s product offerings are sold to OEM customers. The segment sells these products both directly, utilizing a highly technical sales force, and indirectly, through resellers and distributors.

Vision

The Vision segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless, recorder and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification (“RFID”) technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The vast majority of the segment’s product offerings are sold to OEM customers. The segment sells these products both directly, utilizing a highly technical sales force, and indirectly, through resellers and distributors.

Precision Motion

The Precision Motion segment designs, manufactures and markets optical and inductive encoders, precision motor and motion control sub-assemblies, servo drives, air bearings, and air bearing spindles to customers worldwide. The vast majority of the

segment’s product offerings are sold to OEM customers. The segment sells these products both directly, utilizing a highly technical sales force, and indirectly, through resellers and distributors.

Reportable Segment Financial Information

Revenue, gross profit, gross profit margin, operating income (loss), and depreciation and amortization expenses by reportable segment were as follows (in thousands, except percentage data):

 

Three Months Ended

 

 

April 2,

 

 

April 3,

 

Revenue

2021

 

 

2020

 

Photonics

$

58,493

 

 

$

55,140

 

Vision

 

67,636

 

 

 

69,008

 

Precision Motion

 

36,455

 

 

 

31,320

 

Total

$

162,584

 

 

$

155,468

 

 

 

Three Months Ended

 

 

April 2,

 

 

April 3,

 

Gross Profit

2021

 

 

2020

 

Photonics

$

28,109

 

 

$

24,661

 

Vision

 

26,926

 

 

 

26,575

 

Precision Motion

 

16,077

 

 

 

13,908

 

Unallocated Corporate and Shared Services

 

(2,372

)

 

 

(699

)

Total

$

68,740

 

 

$

64,445

 

 

 

Three Months Ended

 

 

April 2,

 

 

April 3,

 

Gross Profit Margin

2021

 

 

2020

 

Photonics

 

48.1

%

 

 

44.7

%

Vision

 

39.8

%

 

 

38.5

%

Precision Motion

 

44.1

%

 

 

44.4

%

Total

 

42.3

%

 

 

41.5

%

 

 

Three Months Ended

 

 

April 2,

 

 

April 3,

 

Operating Income (Loss)

2021

 

 

2020

 

Photonics

$

12,395

 

 

$

8,915

 

Vision

 

3,366

 

 

 

5,634

 

Precision Motion

 

7,446

 

 

 

6,538

 

Unallocated Corporate and Shared Services

 

(12,108

)

 

 

(7,837

)

Total

$

11,099

 

 

$

13,250

 

 

 

Three Months Ended

 

 

April 2,

 

 

April 3,

 

Depreciation and Amortization Expenses

2021

 

 

2020

 

Photonics

$

2,898

 

 

$

2,649

 

Vision

 

5,275

 

 

 

5,277

 

Precision Motion

 

1,607

 

 

 

1,353

 

Unallocated Corporate and Shared Services

 

69

 

 

 

51

 

Total

$

9,849

 

 

$

9,330

 

 

Revenue by Geography

The Company aggregates geographic revenue based on the customer location where products are shipped to. Revenue from these customers was as follows (in thousands):

 

Three Months Ended

 

 

April 2,

 

 

April 3,

 

 

2021

 

 

2020

 

United States

$

59,230

 

 

$

59,205

 

Germany

 

22,363

 

 

 

23,233

 

Rest of Europe

 

35,575

 

 

 

33,085

 

China

 

22,551

 

 

 

15,404

 

Rest of Asia-Pacific

 

20,747

 

 

 

21,700

 

Other

 

2,118

 

 

 

2,841

 

Total

$

162,584

 

 

$

155,468

 

The majority of revenue from our Photonics, Vision and Precision Motion segments is generated from sales to customers within the United States and Europe. Each segment also generates revenue across the other geographies, with no significant concentration of any segment’s remaining revenue.

Revenue by End Market

The Company primarily operates in two end markets: the medical market and advanced industrial market. Revenue by end market was approximately as follows:

 

Three Months Ended

 

 

April 2,

 

 

April 3,

 

 

2021

 

 

2020

 

Medical

 

55

%

 

 

58

%

Advanced Industrial

 

45

%

 

 

42

%

Total

 

100

%

 

 

100

%

The majority of revenue from the Photonics and Precision Motion segments is generated from sales to customers in the advanced industrial market. The majority of revenue from the Vision segment is generated from sales to customers in the medical market.